The South Korean Samsung Group, the parent company of the electronics and computer giant Samsung Electronics, is negotiating the acquisition of Biogen, in a deal that may reflect to the biotechnology company The American is worth more than 50 trillion South Korean won ($ 42 billion). According to a report by the South Korean economic daily, Korea Economic Daily, the value of the deal would reflect a premium of 11% over Biogen’s current market value, which is slightly below $ 35 billion. “Samsung is negotiating with the selling side to buy Biogen,” a senior official at a global investment bank, whose name has not been revealed, told the newspaper today (Wednesday). Samsung and Biogen already agreed a decade ago to set up a drug development venture …
Comments
Articles Main Site
Note: This article has been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here